Week 1 Embryonic Development (Blastocyst): Stages and Dynamics, Classification

Human embryonic development during Week 1 is an exceptionally complex biological process that begins at the moment of gamete fusion and concludes with the successful implantation of the blastocyst into the uterine wall. This article provides a detailed overview of the molecular mechanisms of fertilization, the day‑by‑day chronology of cell cleavage, modern systems for morphological assessment of blastocyst quality, and the key stages of implantation into the endometrium.

Physiology of Fertilization

The process of fertilization begins when the gametes meet in the ampulla of the uterine tube, where the sperm must overcome several barriers before fusing with the secondary oocyte.

Stages of Fertilization

• Capacitation. Within the female reproductive tract, the spermatozoon loses its glycoprotein coat and acquires the ability to fertilize the oocyte.
• Penetration Through Corona Radiata. The spermatozoon traverses the outer layer of oocyte‑associated cells with the help of hyaluronidase, which dissolves the matrix between the follicular cells.
• Acrosomal Reaction. Upon reaching the zona pellucida, the sperm binds to the glycoprotein ZP3, which triggers the acrosome reaction — the release of proteases (primarily acrosin) that enable it to penetrate this barrier.
• Membrane Fusion. After traversing the zona pellucida, the gamete plasma membranes fuse. It is important to note that only the sperm head enters the oocyte cytoplasm, while the tail remains outside.
• Zona Reaction. In response to sperm entry, the oocyte is activated: cortical granules release enzymes that modify the zona pellucida (known as the cortical or zona reaction), rendering it impermeable to additional sperm and thereby preventing polyspermy.
• Completion of Meiosis. The oocyte completes meiosis II along with the zona reaction, forming a mature ovum with a haploid chromosome set (23,X) and the second polar body.
• Formation of Pronuclei. The sperm nucleus then decondenses to form the male pronucleus, while the female pronucleus develops from the oocyte nucleus. Over the next several hours, the pronuclei migrate toward the center of the cell, synchronizing their cell cycles.

Completion of Fertilization and Zygote Formation

Within 18–24 hours after fusion, the pronuclei dissolve their nuclear envelopes, and the chromosomes align on a single mitotic spindle, completing true fertilization — the formation of a diploid zygote (46,XX or 46,XY).

This moment marks the beginning of embryogenesis. The earliest cell divisions are regulated by maternal RNAs and proteins stored within the oocyte, whereas activation of the embryonic genome occurs only at the 4–8‑cell stage.

Dynamics of Early Human Embryogenesis

The early stages of human embryogenesis include the sequential processes of cleavage, compaction, and blastulation.

Day 0–1: Zygote Formation (2n, 4c)

After fertilization of the oocyte by the spermatozoon, a zygote is formed carrying a diploid chromosome set (2n) and a tetraploid DNA content (4c). At this stage, the second meiotic division is completed, accompanied by the following processes:

• The male and female pronuclei form (visible under the microscope 16–20 hours after fertilization);
• Maternal mRNAs are activated that regulate the earliest stages of embryonic development;
• Protein synthesis is initiated required for subsequent cleavage.

The first mitotic division of the zygote occurs 24–30 hours after fertilization, producing two blastomeres. At this stage, embryologists evaluate several parameters:

Presence and characteristics of pronuclei (PN)

• 2PN (normal). Two clearly visible pronuclei (male and female);
• 1PN/3PN (abnormal). Possible genetic abnormalities;
• 0PN. Failed fertilization.

Pronuclear position

• Central;
• Peripheral.

Number and position of polar bodies

• 2 polar bodies (normal);
• 1 or > 2 (may indicate abnormalities).

Pronuclear symmetry

• Equal in size;
• Unequal in size (less favorable).

Vacuoles or other inclusions

• Absent (favorable);
• Present (may reduce quality).

This stage is characterized by asynchronous division: approximately 30 % of embryos show uneven cytoplasmic distribution between blastomeres, which may be related to oocyte quality or specifics of embryonic genome activation. At the same time, the maternal‑to‑zygotic transition (MZT) begins, during which maternal mRNAs are degraded and transcription of embryonic genes is gradually activated. This marks the shift of developmental control from maternal factors to embryonic ones.

Day 2: Early Cleavage Stage

By Day 2, the embryo is at an early cleavage stage and normally consists of 2–4 blastomeres. Evaluation includes several key parameters:

Number of blastomeres

• 4 cells (good);
• 3 cells (acceptable);
• 2 cells (slight developmental delay);
• 1 cell or > 4 cells (abnormal).

The number of cells should correspond to developmental timing — on average, one division every 24 hours.

Size and shape of blastomeres

• A. Ideal (smooth, equally sized);
• B. Good (minor size differences);
• C. Fair (noticeable asymmetry);
• D. Poor (markedly unequal sizes).

Degree of fragmentation

• < 10 % (excellent);
• 10–25 % (good);
• 25–50 % (fair);
• < 50 % (poor).

Multinucleation

• 0 — absent (normal);
• 1 — present (negative indicator).

Best‑quality embryos at this stage have:

• 4 equal blastomeres;
• F1 — Minimal fragmentation (< 10 %);
• No multinucleation.

Day 2–3: 6–8‑Cell Stage and Developmental Assessment

During Days 2–3, the embryo undergoes the second and third mitotic divisions, reaching the 4–8‑cell stage. During this period, zygotic genome activation (ZGA) occurs. At the 4- 8‑cell stage (~Day 3), active expression of embryonic genes begins, including key transcription factors (OCT4, NANOG) responsible for maintaining pluripotency and supporting further development. Simultaneously, the first adhesive junctions between blastomeres are established. These interactions are mediated by cell‑adhesion proteins, preparing the embryo for compaction at later stages.

Day 3 is denoted as the cleavage stage (6–8 cells). Evaluation includes:

Number of blastomeres (cells)

Ideal on D3: 8 cells (acceptable range: 6–10).

• 6 cells — possible developmental delay.
• > 10 cells — accelerated division (may indicate chromosomal abnormalities).

Degree of fragmentation (%)

Size and symmetry of blastomeres

• A (ideal). All cells equal in size, no abnormalities.
• B (good). Minor asymmetry (≤ 20 % difference).
• C (fair). Pronounced asymmetry (cell sizes vary a lot).
• D (poor). Irregular, deformed blastomeres.

Multinucleation (several nuclei within a single cell — an unfavorable sign)

• Absent (best option): each cell contains a single nucleus.
• Present (poor prognosis): associated with increased risk of aneuploidy.

Day 3–4: Morula Stage

By Days 3–4, the embryo reaches the morula stage, characterized by an increase to 16–32 cells due to ongoing mitotic divisions. A key event that marks this period is compaction — the tightening of blastomeres mediated by E‑cadherin (CDH1), creating strong intercellular junctions necessary for subsequent cavitation. This is also the stage when early cell differentiation into inner cells (future inner cell mass, ICM) and outer cells (future trophectoderm, TE) begins.

Evaluation of the morula or early blastocyst on Day 4 includes:

1. Developmental Stage (morula, compacted morula, early blastocyst).

2. Quality of Compaction (degree of cell fusion)

• A (excellent). Complete compaction; cells are uniformly fused.
• B (good). Incomplete compaction; small areas with distinguishable cells.
• C (fair). Weak compaction; many individual cells remain visible.

3. Fragmentation and Abnormalities

• F1. Minimal fragmentation (< 10 %);
• F2. Moderate fragmentation (10–25 %);
• F3. Significant fragmentation (< 25 %);
• MN. Multinucleation (poor prognosis).

Day 5: Blastocyst Formation and Cavitation

On Day 5, an early blastocyst forms, characterized by cavitation when a blastocoel, a fluid‑filled cavity, is formed via active ion transport (a Na⁺-dependent mechanism) and aquaporin action.

During this period, cell‑line differentiation is completed: the trophectoderm (TE) forms the outer layer responsible for generating extraembryonic structures, including the placenta. The inner cell mass (ICM) becomes the embryoblast, which will give rise to the embryonic tissues. Key transcription factors regulating further embryonic development are also activated at this stage.

Day 6–7: Blastocyst Expansion and Hatching

By Days 5–6, the blastocyst reaches the final stage of preimplantation development. The blastocoel expands, and the trophectoderm becomes thinner, preparing for hatching. The inner cell mass differentiates into two subpopulations: the epiblast — the precursor of the embryo proper; and the hypoblast — the precursor of extraembryonic mesoderm. The final event is hatching: the blastocyst emerges from the zona pellucida, which is essential for successful implantation into the endometrium.

Blastocyst Classification

Gardner & Schoolcraft System (1999)

Blastocysts are evaluated using morphological criteria according to the Gardner and Schoolcraft (1999) system, widely used in assisted reproductive technologies (ART) to select the most viable embryos for transfer.

Degree of Blastocyst Expansion

This indicator reflects the extent of blastocoel development and the blastocyst’s readiness for hatching (escape from the zona pellucida):

• BL1. Early blastocyst: the cavity occupies < 50 % of the embryo.
• BL2. Intermediate blastocyst: the cavity occupies > 50 %, the zona pellucida is still thick.
• BL3. Full blastocyst: the cavity fills nearly the entire embryo; the zona pellucida becomes thinned.
• BL4. Expanded blastocyst: maximal cavity expansion; the zona pellucida is extremely thin.
• BL5. Hatching blastocyst: the embryo begins to emerge from the zona pellucida.
• BL6. Fully hatched blastocyst.

Quality of Inner Cell Mass (ICM)

This structure represents the future embryo (not the trophectoderm). Evaluated by cell density and compactness:

• A (Excellent). Numerous, tightly packed cells with clear borders.
• B (Good). Moderate number of cells; slight fragmentation possible.
• C (Poor). Few cells; marked fragmentation or degeneration.

Quality of Trophectoderm (TE)

This structure gives rise to the future placenta and extraembryonic tissues. Evaluated by cellular organization:

• A (Excellent). Many uniform cells forming a cohesive layer.
• B (Good). Mild heterogeneity or slightly sparse areas.
• C (Poor). Few, irregular, or vacuolated cells.

The ESHRE classification is also used to evaluate blastocysts. The ESHRE (European Society of Human Reproduction and Embryology) system provides a modern, standardized approach to evaluating blastocyst quality.

ESHRE Classification (Istanbul Consensus, 2011)

The system includes three basic parameters:

1. Blastocyst expansion stage — scored from 1 to 6.
2. Inner cell mass quality (ICM) — A, B, C.
3. Trophectoderm (TE) quality — A, B, C.

Blastocyst expansion stage

Development of the blastocoel and the embryo’s readiness for hatching:

• 1 (Early blastocyst). The cavity occupies < 50 % of the total volume; cells remain compact.
• 2 (Blastocyst). The cavity occupies > 50 %, the zona pellucida is still thick.
• 3 (Full blastocyst). The cavity occupies nearly the entire embryo; the zona pellucida begins to thin.
• 4 (Expanded blastocyst). Maximal expansion; the zona pellucida is very thin.
• 5 (Hatching blastocyst). The embryo begins to emerge from the zona pellucida.
• 6 (Hatched blastocyst). Fully hatched blastocyst.

Higher stages (4–6) are associated with better implantation potential.

Quality of Inner Cell Mass (ICM)

The ICM represents the future embryo.

• A (Excellent). Numerous, tightly packed cells with well‑defined borders.
• B (Good). Moderate number of cells; slight fragmentation possible.
• C (Poor). Few cells; marked degeneration or vacuolization.

A is the best grade; C is the poorest.

Quality of Trophectoderm (TE)

The TE gives rise to the placenta and extraembryonic tissues.

• A (Excellent). Many uniform cells forming a clear epithelial layer.
• B (Good). Mild heterogeneity; occasional sparse cells.
• C (Poor). Few, irregular, or vacuolated cells.

The ESHRE classification is notable for its standardized approach. It is used more commonly in Europe, whereas the Gardner system is widely used in the United States. However, the principles of evaluation are similar in both systems.

Find more scientifically accurate content on our social media

Subscribe and don’t miss out the latest resources

Blastocyst Implantation

The next stage is implantation of the blastocyst. The process can only be successful with highly coordinated interactions between embryonic and maternal systems. This means sequential hatching, adhesion, invasion, and formation of the early placental structures, all regulated by complex molecular mechanisms. Blastocyst implantation into the endometrium begins on Days 5–7 of embryonic development.

Blastocyst implantation occurs in several stages:

1. Hatching

The initial step is hatching, when the blastocyst leaves the zona pellucida. This process is driven by enzymatic activity and mechanical factors. The former covers secretion of serine proteases (including ST6) and lysine‑dependent enzymes such as cathepsins and plasmin produced by the trophectoderm. The latter comprise rhythmic contractions of the blastocyst and an increase in blastocoel volume both referred to as mechanical factors. Once freed from the zona pellucida, the exposed trophectoderm can come into direct contact with the endometrium.

2. Adhesion

Adhesion of the blastocyst to the endometrium is mediated by complex molecular interactions. Integrins (αVβ3, α4β1) on the trophectoderm surface bind to corresponding ligands in the endometrium and play the key role in this process. L‑selectin on trophoblast cells also contributes to the adhesion through interactions with oligosaccharides on the endometrial epithelium. A critical factor is the local downregulation of mucins (MUC1) in the endometrium, which facilitates intimate contact between embryonic and maternal tissues.

3. Invasion and Trophoblast Differentiation

Subsequent differentiation of the trophectoderm produces two functionally distinct layers: cytotrophoblast — the inner proliferative layer, expressing markers such as Ki‑67 and EGFR, and syncytiotrophoblast — the outer invasive layer.

The syncytiotrophoblast forms through fusion of cytotrophoblasts, mediated by endogenous retroviral proteins Syncytin‑1 and Syncytin‑2. The invasive activity of the syncytiotrophoblast is supported by secretion of matrix metalloproteinases (MMP‑2, MMP‑9), which degrade extracellular matrix; expression of integrins (α1β1, α5β1), promoting migration into the endometrial stroma; and interaction with decidual cells via HLA‑G, ensuring immune tolerance.

4. Decidualization

In parallel, the endometrium undergoes profound changes known as decidualization — the transformation of stromal cells under the influence of progesterone. Decidualized cells exhibit increased size, accumulation of glycogen and lipids, and an altered secretory profile (production of IGFBP‑1, PRL, IL‑11). A crucial aspect is immune tolerance, involving suppression of NK‑cell activity via HLA‑E/G, regulation of macrophages (shift toward an M2 phenotype), and activation of regulatory T cells (FoxP3⁺).

5. Onset of hCG Secretion

The syncytiotrophoblast begins secreting human chorionic gonadotropin (hCG) as early as Days 7–8, playing a key role in maintaining pregnancy. hCG stimulates the corpus luteum to continue progesterone secretion via LH receptors. It also promotes angiogenesis by activating VEGF in the endometrium and modulates the immune response, shifting it toward a Th2‑dominant cytokine profile.